presbyopia

Feb 03, 2026

Novo Nordisk A/S Announces that CagriSema Delivered Superior Outcomes in REIMAGINE 2; Sanofi’s Venglustat Clears all Primary Hurdles in Phase 3 Gaucher Disease Trial; Kyowa Kirin Reacquires Full Development and Commercialization Rights for Rocatinlimab; IMFINZI Receives CHMP Recommendation for Perioperative Treatment in Patients with Resectable Gastric and Gastroesophageal Cancers; Tenpoint Wins FDA Approval for First-Ever Combination Presbyopia Eye Drop

Aug 06, 2025

From Sight to Insight: The Rise of Smart Ophthalmological Devices in Eye Care

Aug 23, 2023

Contact Lenses: A Comprehensive Guide to Vision Correction and Beyond

Jan 04, 2023

Insights Into the Evolving Landscape of the Ocular Implants Market

Jun 21, 2021

How will Pharmacotherapies help the growing number of Presbyopes?

Jun 16, 2021

How Pharmaceutical Companies Are Mitigating The Gap In The Eye Disorders Treatment Market

Newsletter/Whitepaper